Clinical Trials Browser

Phase 1/2 × PHY 906 × Gastrointestinal × Clear all

NCT00411762 2015-03-27

A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma

Phase 1/2 Completed

25 enrolled 5 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00076609 2007-03-28

Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma

Phase 1/2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00036517 2005-06-24

Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer

Phase 1/2 Terminated

Gastrointestinal

Diarrhea, Colorectal Neoplasms